Excessive Astrocyte-Derived Neurotrophin-3 Contributes to the Abnormal Neuronal Dendritic Development in a Mouse Model of Fragile X Syndrome

English version České info

Fragile X syndrome (FXS) is a form of inherited mental retardation in humans that results from expansion of a CGG repeat in the Fmr1 gene. Recent studies suggest a role of astrocytes in neuronal development. However, the mechanisms involved in the regulation process of astrocytes from FXS remain unclear. In this study, we found that astrocytes derived from a Fragile X model, the Fmr1 knockout (KO) mouse which lacks FMRP expression, inhibited the proper elaboration of dendritic processes of neurons in vitro. Furthermore, astrocytic conditioned medium (ACM) from KO astrocytes inhibited proper dendritic growth of both wild-type (WT) and KO neurons. Inducing expression of FMRP by transfection of FMRP vectors in KO astrocytes restored dendritic morphology and levels of synaptic proteins. Further experiments revealed elevated levels of the neurotrophin-3 (NT-3) in KO ACM and the prefrontal cortex of Fmr1 KO mice. However, the levels of nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF), glial cell-derived neurotrophic factor (GDNF), and ciliary neurotrophic factor (CNTF) were normal. FMRP has multiple RNA–binding motifs and is involved in translational regulation. RNA–binding protein immunoprecipitation (RIP) showed the NT-3 mRNA interacted with FMRP in WT astrocytes. Addition of high concentrations of exogenous NT-3 to culture medium reduced the dendrites of neurons and synaptic protein levels, whereas these measures were ameliorated by neutralizing antibody to NT-3 or knockdown of NT-3 expression in KO astrocytes through short hairpin RNAs (shRNAs). Prefrontal cortex microinjection of WT astrocytes or NT-3 shRNA infected KO astrocytes rescued the deficit of trace fear memory in KO mice, concomitantly decreased the NT-3 levels in the prefrontal cortex. This study indicates that excessive NT-3 from astrocytes contributes to the abnormal neuronal dendritic development and that astrocytes could be a potential therapeutic target for FXS.

Vyšlo v časopise: Excessive Astrocyte-Derived Neurotrophin-3 Contributes to the Abnormal Neuronal Dendritic Development in a Mouse Model of Fragile X Syndrome. PLoS Genet 8(12): e32767. doi:10.1371/journal.pgen.1003172
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pgen.1003172

Souhrn

Zdroje

1. FengY, ZhangF, LokeyLK, ChastainJL, LakkisL, et al. (1995) Translational suppression by trinucleotide repeat expansion at FMR1. Science 268: 731–734.

2. PierettiM, ZhangFP, FuYH, WarrenST, OostraBA, et al. (1991) Absence of expression of the FMR-1 gene in fragile X syndrome. Cell 66: 817–822.

3. BagniC, GreenoughWT (2005) From mRNP trafficking to spine dysmorphogenesis: the roots of fragile X syndrome. Nat Rev Neurosci 6: 376–387.

4. BearMF, HuberKM, WarrenST (2004) The mGluR theory of fragile X mental retardation. Trends Neurosci 27: 370–377.

5. ZhaoMG, ToyodaH, KoSW, DingHK, WuLJ, et al. (2005) Deficits in trace fear memory and long-term potentiation in a mouse model for fragile X syndrome. J Neurosci 25: 7385–7392.

6. SkinnerM, HooperS, HattonDD, RobertsJ, MirrettP, et al. (2005) Mapping nonverbal IQ in young boys with fragile X syndrome. Am J Med Genet A 132A: 25–32.

7. JinP, WarrenST (2003) New insights into fragile X syndrome: from molecules to neurobehaviors. Trends Biochem Sci 28: 152–158.

8. BakkerCE, de Diego OteroY, BontekoeC, RaghoeP, LuteijnT, et al. (2000) Immunocytochemical and biochemical characterization of FMRP, FXR1P, and FXR2P in the mouse. Exp Cell Res 258: 162–170.

9. DevysD, LutzY, RouyerN, BellocqJP, MandelJL (1993) The FMR-1 protein is cytoplasmic, most abundant in neurons and appears normal in carriers of a fragile X premutation. Nat Genet 4: 335–340.

10. MiyashiroKY, Beckel-MitchenerA, PurkTP, BeckerKG, BarretT, et al. (2003) RNA cargoes associating with FMRP reveal deficits in cellular functioning in Fmr1 null mice. Neuron 37: 417–431.

11. ToddPK, MackKJ, MalterJS (2003) The fragile X mental retardation protein is required for type-I metabotropic glutamate receptor-dependent translation of PSD-95. Proc Natl Acad Sci U S A 100: 14374–14378.

12. ConsortiumTD-BFX (1994) Fmr1 knockout mice: a model to study fragile X mental retardation. Cell 78: 23–33.

13. FranklandPW, WangY, RosnerB, ShimizuT, BalleineBW, et al. (2004) Sensorimotor gating abnormalities in young males with fragile X syndrome and Fmr1-knockout mice. Mol Psychiatry 9: 417–425.

14. WangH, WuLJ, KimSS, LeeFJ, GongB, et al. (2008) FMRP acts as a key messenger for dopamine modulation in the forebrain. Neuron 59: 634–647.

15. HaberM, ZhouL, MuraiKK (2006) Cooperative astrocyte and dendritic spine dynamics at hippocampal excitatory synapses. J Neurosci 26: 8881–8891.

16. NishidaH, OkabeS (2007) Direct astrocytic contacts regulate local maturation of dendritic spines. J Neurosci 27: 331–340.

17. PfriegerFW, BarresBA (1997) Synaptic efficacy enhanced by glial cells in vitro. Science 277: 1684–1687.

18. UllianEM, SappersteinSK, ChristophersonKS, BarresBA (2001) Control of synapse number by glia. Science 291: 657–661.

19. PaceyLK, DoeringLC (2007) Developmental expression of FMRP in the astrocyte lineage: implications for fragile X syndrome. Glia 55: 1601–1609.

20. JacobsS, DoeringLC (2010) Astrocytes prevent abnormal neuronal development in the fragile x mouse. J Neurosci 30: 4508–4514.

21. Beckel-MitchenerA, GreenoughWT (2004) Correlates across the structural, functional, and molecular phenotypes of fragile X syndrome. Ment Retard Dev Disabil Res Rev 10: 53–59.

22. BallasN, LioyDT, GrunseichC, MandelG (2009) Non-cell autonomous influence of MeCP2-deficient glia on neuronal dendritic morphology. Nat Neurosci 12: 311–317.

23. IpNY, BoultonTG, LiY, VerdiJM, BirrenSJ, et al. (1994) CNTF, FGF, and NGF collaborate to drive the terminal differentiation of MAH cells into postmitotic neurons. Neuron 13: 443–455.

24. VentimigliaR, MatherPE, JonesBE, LindsayRM (1995) The neurotrophins BDNF, NT-3 and NT-4/5 promote survival and morphological and biochemical differentiation of striatal neurons in vitro. Eur J Neurosci 7: 213–222.

25. LohofAM, IpNY, PooMM (1993) Potentiation of developing neuromuscular synapses by the neurotrophins NT-3 and BDNF. Nature 363: 350–353.

26. WangH, KuL, OsterhoutDJ, LiW, AhmadianA, et al. (2004) Developmentally-programmed FMRP expression in oligodendrocytes: a potential role of FMRP in regulating translation in oligodendroglia progenitors. Hum Mol Genet 13: 79–89.

27. ZalfaF, GiorgiM, PrimeranoB, MoroA, Di PentaA, et al. (2003) The fragile X syndrome protein FMRP associates with BC1 RNA and regulates the translation of specific mRNAs at synapses. Cell 112: 317–327.

28. LuR, WangH, LiangZ, KuL, O'Donnell WT, et al. (2004) The fragile X protein controls microtubule-associated protein 1B translation and microtubule stability in brain neuron development. Proc Natl Acad Sci U S A 101: 15201–15206.

29. ZalfaF, EleuteriB, DicksonKS, MercaldoV, De RubeisS, et al. (2007) A new function for the fragile X mental retardation protein in regulation of PSD-95 mRNA stability. Nat Neurosci 10: 578–587.

30. HanCJ, O'TuathaighCM, van TrigtL, QuinnJJ, FanselowMS, et al. (2003) Trace but not delay fear conditioning requires attention and the anterior cingulate cortex. Proc Natl Acad Sci U S A 100: 13087–13092.

31. YuskaitisCJ, BeurelE, JopeRS (2010) Evidence of reactive astrocytes but not peripheral immune system activation in a mouse model of Fragile X syndrome. Biochim Biophys Acta 1802: 1006–1012.

32. JacobsS, NathwaniM, DoeringLC (2010) Fragile X astrocytes induce developmental delays in dendrite maturation and synaptic protein expression. BMC Neurosci 11: 132.

33. LobsigerCS, ClevelandDW (2007) Glial cells as intrinsic components of non-cell-autonomous neurodegenerative disease. Nat Neurosci 10: 1355–1360.

34. SegalRA, TakahashiH, McKayRD (1992) Changes in neurotrophin responsiveness during the development of cerebellar granule neurons. Neuron 9: 1041–1052.

35. von BartheldCS, KinoshitaY, PrevetteD, YinQW, OppenheimRW, et al. (1994) Positive and negative effects of neurotrophins on the isthmo-optic nucleus in chick embryos. Neuron 12: 639–654.

36. Sajdel-SulkowskaEM, XuM, KoibuchiN (2009) Increase in cerebellar neurotrophin-3 and oxidative stress markers in autism. Cerebellum 8: 366–372.

37. FernandesBS, GamaCS, WalzJC, CereserKM, FriesGR, et al. (2010) Increased neurotrophin-3 in drug-free subjects with bipolar disorder during manic and depressive episodes. J Psychiatr Res 44: 561–565.

38. CondorelliDF, Dell'AlbaniP, MudoG, TimmuskT, BelluardoN (1994) Expression of neurotrophins and their receptors in primary astroglial cultures: induction by cyclic AMP-elevating agents. J Neurochem 63: 509–516.

39. RudgeJS, AldersonRF, PasnikowskiE, McClainJ, IpNY, et al. (1992) Expression of Ciliary Neurotrophic Factor and the Neurotrophins-Nerve Growth Factor, Brain-Derived Neurotrophic Factor and Neurotrophin 3-in Cultured Rat Hippocampal Astrocytes. Eur J Neurosci 4: 459–471.

40. LiR, BerndP (1999) Neurotrophin-3 increases neurite outgrowth and apoptosis in explants of the chicken neural plate. Dev Neurosci 21: 12–21.

41. LuB, PangPT, WooNH (2005) The yin and yang of neurotrophin action. Nat Rev Neurosci 6: 603–614.

42. LindholmD, CastrenE, TsoulfasP, KolbeckR, Berzaghi MdaP, et al. (1993) Neurotrophin-3 induced by tri-iodothyronine in cerebellar granule cells promotes Purkinje cell differentiation. J Cell Biol 122: 443–450.

43. LindholmD, da Penha BerzaghiM, CooperJ, ThoenenH, CastrenE (1994) Brain-derived neurotrophic factor and neurotrophin-4 increase neurotrophin-3 expression in the rat hippocampus. Int J Dev Neurosci 12: 745–751.

44. PatzS, WahleP (2004) Neurotrophins induce short-term and long-term changes of cortical neurotrophin expression. Eur J Neurosci 20: 701–708.

45. WuVW, NishiyamaN, SchwartzJP (1998) A culture model of reactive astrocytes: increased nerve growth factor synthesis and reexpression of cytokine responsiveness. J Neurochem 71: 749–756.

46. RaffioniS, BradshawRA, BuxserSE (1993) The receptors for nerve growth factor and other neurotrophins. Annu Rev Biochem 62: 823–850.

47. DechantG, BiffoS, OkazawaH, KolbeckR, PottgiesserJ, et al. (1993) Expression and binding characteristics of the BDNF receptor chick trkB. Development 119: 545–558.

48. McCarthyKD, de VellisJ (1980) Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue. J Cell Biol 85: 890–902.

49. RanaOR, SchauerteP, HommesD, SchwingerRH, SchroderJW, et al. (2010) Mechanical stretch induces nerve sprouting in rat sympathetic neurocytes. Auton Neurosci 155: 25–32.

50. HelkeCJ, Verdier-PinardD (2000) Neurotrophins alter the numbers of neurotransmitter-ir mature vagal/glossopharyngeal visceral afferent neurons in vitro. Brain Res 884: 206–212.

51. HuertaPT, SunLD, WilsonMA, TonegawaS (2000) Formation of temporal memory requires NMDA receptors within CA1 pyramidal neurons. Neuron 25: 473–480.

52. ZhaoMG, KoSW, WuLJ, ToyodaH, XuH, et al. (2006) Enhanced presynaptic neurotransmitter release in the anterior cingulate cortex of mice with chronic pain. J Neurosci 26: 8923–8930.